Abstract: A proportional valve (100) is provided that includes a movable armature (104) within a body (102), with the armature (104) including a poppet (107) and with the body (102) including one or more inflow ports (135) and an outflow bore (123), a valve seat (120) located on a projecting valve seat structure (119), with the valve seat (120) including a valve orifice (130) in fluid communication with the one or more inflow ports (135) and the outflow bore (123), and a flow flange (116) extending from the poppet (107) and including a flow flange wall (117) that surrounds the valve seat (120), forming a flange inflow channel (129) of a predetermined cross-sectional inflow area between the flow flange wall (117) and the valve seat structure (119), wherein the poppet (107) moves between closed and opened positions without changing the predetermined cross-sectional inflow area provided by the inflow channel (129).

Abstract: A proportional valve (100) is provided that includes a movable armature (104) within a body (102), with the armature (104) including a poppet (107) and with the body (102) including one or more inflow ports (135) and an outflow bore (123), a valve seat (120) located on a projecting valve seat structure (119), with the valve seat (120) including a valve orifice (130) in fluid communication with the one or more inflow ports (135) and the outflow bore (123), and a flow flange (116) extending from the poppet (107) and including a flow flange wall (117) that surrounds the valve seat (120), forming a flange inflow channel (129) of a predetermined cross-sectional inflow area between the flow flange wall (117) and the valve seat structure (119), wherein the poppet (107) moves between closed and opened positions without changing the predetermined cross-sectional inflow area provided by the inflow channel (129).

Abstract: The invention relates to an antimicrobially effective composition which comprises a) 0.001 to 1% by weight of bispyridiniumalkane, b) humectant and c) water. The composition has an osmolality of from 230 to 350 mOsmol/kg and is free from surfactant. It is used as wound and mucosa antiseptic.

Abstract: The displacement sensor (100) includes a rod (103) including a conical convex graduated magnetically anomalous region (105) and a magnetic sensor (110) located in close proximity to the concical convex graduated magnetically anomalous region (105). The magnetic sensor (110) generates a positional signal that is related to the position of the concical convex graduated magnetically anomalous region (105) in relation to the magnetic sensor (110).

Abstract: The invention relates to an antimicrobially effective composition which comprises a) 0.001 to 1% by weight of bispyridiniumalkane, b) humectant and c) water. The composition has an osmolality of from 230 to 350 mOsmol/kg and is free from surfactant. It is used as wound and mucosa antiseptic.

Abstract: The invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition for the treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens, where the composition comprises from 0.005 to 5% by weight octenidine dihydrochloride, and a corresponding composition.

Abstract: A displacement sensor (100) is provided according to the invention. The displacement sensor (100) includes a rod (103) including a graduated magnetically anomalous region (105) and a magnetic sensor (110) located in close proximity to the graduated magnetically anomalous region (105). The magnetic sensor (110) generates a positional signal that is related to the position of the graduated magnetically anomalous region (105) in relation to the magnetic sensor (110).

Abstract: The invention relates to antimicrobial preparations which comprise octenidine dihydrochloride in liposomes. The invention additionally relates to a process for manufacturing the preparations and to the use of phospholipids for manufacturing antimicrobial preparations which comprise octenidine dihydrochloride. The preparations show a low cytoxicity.

Abstract: The invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition for the treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens, where the composition comprises from 0.005 to 5% by weight octenidine dihydrochloride, and a corresponding composition.